March 20 (Reuters) – U.S. consumer health products maker Prestige Consumer Healthcare said on Friday it would buy the Breathe Right brand and other assets from Foundation Consumer Healthcare in a deal valued at $1.045 billion.
The deal also equates to about $900 million after tax benefits, Prestige said.
The acquisition of Breathe Right, a popular nasal strip brand, represents the company’s expansion into a new category.
The Breathe Right brand, set to be the largest in Prestige’s portfolio, had a revenue of about $200 million and core profit of $95 million in 2025.
“Today’s acquisition fits squarely within our disciplined M&A framework and the Breathe Right brand enhances our portfolio over the long-term,” Prestige CEO Ron Lombardi said.
The transaction is expected to close during the first half of 2027.
The company expects this acquisition to be accretive to its core profit.
Prestige, which develops and distributes over-the-counter health and personal care products in North America, Australia and other global markets, beat third-quarter revenue estimates on Thursday.
(Reporting by Sahil Pandey and Koyena Das in Bengaluru; Editing by Shreya Biswas)
